edoc

Items where Author is "Barbier, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2022 | 2020
Number of items: 2.

2022

Merker, M. and Rasigade, J. P. and Barbier, M. and Cox, H. and Feuerriegel, S. and Kohl, T. A. and Shitikov, E. and Klaos, K. and Gaudin, C. and Antoine, R. and Diel, R. and Borrell, S. and Gagneux, S. and Nikolayevskyy, V. and Andres, S. and Crudu, V. and Supply, P. and Niemann, S. and Wirth, T.. (2022) Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis. Nat Commun, 13. p. 5105.

2020

Panje, C. M. and Lupatsch, J. E. and Barbier, M. and Pardo, E. and Lorez, M. and Dedes, K. J. and Aebersold, D. M. and Plasswilm, L. and Gautschi, O. and Schwenkglenks, M. and Swiss Group for Clinical Cancer Research, . (2020) A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of Oncology, 31 (4). pp. 501-506.

This list was generated on Fri Apr 19 00:43:02 2024 CEST.